58. Engineering a Novel Retroviral Envelope to Retarget Retroviral Vectors

Molecular Therapy- United States

doi 10.1016/s1525-0016(16)35071-7

Full Text

Abstract

Available in

Date

Authors

Unknown

Publisher

Elsevier BV

Related search

PostexitSurface Engineering of Retroviral/Lentiviral Vectors

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Q Vectors, Bicistronic Retroviral Vectors for Gene Transfer

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2000English

A New Generation of pPRIG-based Retroviral Vectors

BMC Biotechnology
Biotechnology
2007English

E- Vectors: Development of Novel Self-Inactivating and Self-Activating Retroviral Vectors for Safer Gene Therapy.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Self-Inactivating Retroviral Vectors With Improved RNA Processing

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Introduction for “Safety Considerations for Retroviral Vectors: A Short Review”

Applied Biosafety
ManagementMonitoringMutagenesisPublic HealthEnvironmentalHealthToxicologyPolicyBiotechnologyLawOccupational Health
2004English

Regulation of Mammary Hormone Receptor Metabolism by a Retroviral Envelope Protein

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
1998English

278. Challenges in the Manufacturing of Retroviral Gene Therapy Vectors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Dual-Vector Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy